SSA
GOSS icon

Schonfeld Strategic Advisors’s Gossamer Bio GOSS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-897,388
Closed -$1.1M – 2339
2025
Q2 		$1.1M Buy
897,388
+695,673
+345% +$759K 0.01% 1264
2025
Q1 		$222K Buy
201,715
+47,015
+30% +$54.3K ﹤0.01% 1905
2024
Q4 		$140K Sell
154,700
-81,900
-35% -$70.2K ﹤0.01% 1813
2024
Q3 		$233K Sell
236,600
-919,636
-80% -$885K ﹤0.01% 1757
2024
Q2 		$1.04M Buy
1,156,236
+975,678
+540% +$730K 0.01% 1191
2024
Q1 		$213K Sell
180,558
-189,102
-51% -$208K ﹤0.01% 1758
2023
Q4 		$337K Buy
369,660
+9,760
+3% +$7.21K ﹤0.01% 1397
2023
Q3 		$300K Sell
359,900
-25,500
-7% -$29.4K ﹤0.01% 1326
2023
Q2 		$462K Sell
385,400
-6,400
-2% -$7.97K ﹤0.01% 1250
2023
Q1 		$494K Sell
391,800
-511,700
-57% -$979K ﹤0.01% 1174
2022
Q4 		$1.96M Buy
903,500
+774,156
+599% +$6.37M 0.02% 828
2022
Q3 		$1.55M Buy
129,344
+91,568
+242% +$1.14M 0.01% 1002
2022
Q2 		$315K Sell
37,776
-57,824
-60% -$448K ﹤0.01% 1637
2022
Q1 		$830K Sell
95,600
-26,900
-22% -$259K 0.01% 1085
2021
Q4 		$1.39M Buy
122,500
+22,200
+22% +$264K 0.01% 805
2021
Q3 		$1.26M Buy
+100,300
New +$923K 0.01% 872
2021
Q2 		– Sell
-49,902
Closed -$461K – 2076
2021
Q1 		$461K Buy
49,902
+6,060
+14% +$61.1K 0.01% 1177
2020
Q4 		$423K Buy
+43,842
New +$432K 0.01% 1095

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Schonfeld Strategic Advisors's GOSS Position: Q3 2025 in Review

Schonfeld Strategic Advisors sold out of Gossamer Bio (GOSS) in Q3 2025, closing a stake of 897,388 shares — an estimated $1.1M sold.

Schonfeld Strategic Advisors first reported a position in GOSS in Q4 2020 and held it in 18 quarters. The position peaked at $1.96M in Q4 2022. 164 funds tracked by Wall St. Rank hold GOSS as of Q3 2025.

  • Schonfeld Strategic Advisors reported no remaining Gossamer Bio position as of Q3 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 897,388 Gossamer Bio shares in Q3 2025, an estimated $1.1M.
  • Schonfeld Strategic Advisors first reported a position in Gossamer Bio in Q4 2020 and held it in 18 quarters.
  • Schonfeld Strategic Advisors's Gossamer Bio position peaked at $1.96M in Q4 2022.
  • 164 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.